Poor knowledge of age-related fertility decline and assisted reproduction among healthcare professionals
Désirée García, Rita Vassena, Andrés Prat , Valérie Vernaeve
Reproductive BioMedicine Online Journal. 1472-6483/© 2016

Transcriptomics analysis and human preimplantation development
Thomas Freour, Rita Vassena
Journal of Proteomics, 2016

There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy
K. Lattes, M.A. Checa, R. Vassena, M. Brassesco, and V. Vernaeve5
Human Reproduction, pp. 1–7, December 16, 2016 DOI: 10.1093/humrep/dew306

Use of donor sperm in addition to oocyte donation after repeated implantation failure in normozoospermic patients does not improve live birth rates
A. Blázquez, D. García, A. Rodríguez, R. Vassena, and V. Vernaeve
Human Reproduction, pp. 1–5, 2016

Characteristics and clinical outcomes of patients undergoing fertility treatment by double gamete donation
Anna Blázquez, Rita Vassena, Amelia Rodríguez, Francesc Figueras & Valerie Vernaeve
Journal of Human Fertility, Aug 2016; DOI: 10.1080/14647273.2016.1209577

Oocyte Vitrification Does Not Affect Early Developmental Timings After Intracytoplasmic Sperm Injection for Women Younger Than 30 Years Old
Meritxell Martinez, Albert Obradors, Valérie Vernaeve, Josep Santalo, Rita Vassena
Molecular Reproduction & Development, june 2016 Wiley online library. DOI 10.1002/mrd.22667

Oxidative stress level in fresh ejaculate is not related to semen parameters or to pregnancy rates in cycles with donor oocytes
Aïda Pujol, Albert Obradors, Erica Esteo, Beatriz Costilla, Désireé García, Valérie Vernaeve, Rita Vassena
Journal of Assisted Reproduction and Genetics (2016) 33:529–534 DOI 10.1007/s10815-016-0660-1

PLCζ sequence, protein levels, and distribution in human sperm do not correlate with semen characteristics and fertilization rates after ICSI
Anna Ferrer-Vaquer, Montserrat Barragan, Thomas Freour, Valérie Vernaeve, Rita Vassena
Journal of Assisted Reproduction and Genetics (2016) 33:747–756 DOI 10.1007/s10815-016-0718-0

Semen residual viral load and reproductive outcomes in HIV-infected men undergoing ICSI after extended semen preparation
Maria Jose Zamora, Albert Obradors, Bryan Woodward, Valerie Vernaeve, Rita Vassena
Reproductive BioMedicine Online (2016) 32, 584–590

The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists
Sermon K et al.
Molecular Human Reproduction Journal, Vol.0, No.0 pp. 1–13, 2016 doi:10.1093/molehr/gaw034

Are we ready to inject? Individualized LC-CUSUM training in ICSI
Mercè Durban, Désireé García, Albert Obradors, Valérie Vernaeve, Rita Vassena
Journal of Assisted Reproduction and Genetics. 2016 Mar 16 DOI 10.1007/s10815-016-0686-4

IVM in need of clear definitions
G. Coticchio
Human Reproduction, Vol.0, No.0 pp. 1–3, 2016

Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer
S. Madero, A. Rodriguez, R. Vassena, V. Vernaeve
Human Reproduction, Vol.0, No.0 pp. 1–10, 2016

 “Shoul we worry about the clock?”
P. Bárcena, M. Rodríguez, A. Obradors, V. Vernaeve, R. Vassena
Human Reproduction, Vol.0, No.0 pp. 1–10, 2016

Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis
Anna Blázquez; Désirée García; Amelia Rodríguez; Rita Vassena; Francesc Figueras; Valérie Vernaeve
Journal of Assisted Reproduction and Genetics 2016 Mar; DOI 10.1007/s10815-016-0701-9

Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells
R. Vassena; B. Heindryckx; R. Peco; G. Pennings; A. Raya; K. Sermon; A. Veiga
Human Reproduction 2016 Feb 29; Vol.0, No.0 pp. 1–9, 2016

Increasing fertility knowledge and awareness by tailored education: a randomized controlled trial
Désirée García, Rita Vassena, Andrés Prat, Valérie Vernaeve
Reproductive BioMedicine Online (2016) 32, 113–120

Detection of DNA damage in cumulus cells using a chromatin dispersion assay
Pablo Barcena, Carmen López-Fernández, Carlos García-Ochoa, Albert Obradors, Valérie Vernaeve, Jaime Gosálvez & Rita Vassena.
Systems Biology in Reproductive Medicine 61:5, 277-285

Learning Curves in 3-Dimensional Sonographic Follicle Monitoring During Controlled Ovarian Stimulation
Amelia Rodriguez, MD, Juan José Guillén, MD, Maria Jesus López, MD, Rita Vassena, DVM, PhD, Oriol Coll, MD, PhD, Valerie Vernaeve, MD, PhD.
American Institute of Ultrasound in Medicine. J Ultrasound Med 2014; 33:649–655

PLCζ disruption with complete fertilization failure in normozoospermia
Durban M, Barragán M, Colodrón M, Ferrer-Buitrago M, De Sutter P, Heindryck B, Vernaeve V, Vassena R
J Assist Reprod Genet DOI 10.1007/s10815-015-0496-0.

La vitrification ovocytaire de convenance: l’expérience espagnole
Vernaeve V, López MJ, Poisot F.
Journal international de Médecine 2015 Jan

Influence of Donor, Recipient, and Male Partner Body Mass index on Pregnancy Rates in Oocyte Donation Cycles
Carolina Rubio, Rita Vassena, Désirée García, Valérie Vernaeve, José Ignacio Madero
Presented at the Fertility 2014 Conference, Leeds – UK JBRA Assisted Reproduction 2015;19(2):53-58 doi: 10.5935/1518-0557.20150013

Detection of DNA damage in cumulus cells using a chromatin dispersion assay
Pablo Barcena, Carmen López-Fernández, Carlos García-Ochoa, Albert Obradors, Valerie Vernaeve, Jaime Gosálvez & Rita Vassena
Syst Biol Reprod Med, Early Online: 1–9 © 2015 Taylor & Francis. DOI: 10.3109/19396368.2015.1063739.

Stem cells in reproductive medicine: ready for the patient?
R. Vassena, C. Eguizabal, B. Heindryckx, K. Sermon, C. Simon, A.M.M. van Pelt, A.Veiga, and F. Zambelli on behalf of the ESHRE special interest group Stem Cells
Human Reproduction, Vol.30, No.9 pp. 2014–2021, 2015.

Effect of ribonucleic acid (RNA) isolation methods on putative reference genes messenger RNA abundance in human spermatozoa
Barragán M, Martínez A, Llonch S, Pujol A, Vernaeve V, Vassena R
Andrology doi: 10.1111/andr.12053.

Empty follicle syndrome prevalence and management in oocyte donors
Blazquez A, Guillén JJ, Colomé C, Coll O, Vassena R, Vernaeve V.
Hum Reprod. 2014 Aug 1. pii: deu203.

Paternal age and assisted reproductive outcomes in ICSI donor oocytes: is there an effect of older fathers?
Beguería R, García D, Obradors A, Poisot F, Vassena R, Vernaeve V.
Hum Reprod. 2014 Jul 28. pii: deu189.

Menstrual cycle length in reproductive age women is an indicator of oocyte quality and a candidate marker of ovarian reserve
Vassena R, Vidal R, Coll O, Vernaeve V.
Eur J Obstet Gynecol Reprod Biol. 2014 Apr 12. pii: S0301-2115(14)00177-8. doi: 10.1016/j.ejogrb.2014.03.027.

Learning curves in 3-dimensional sonographic follicle monitoring during controlled ovarian stimulation
Rodriguez A, Guillén JJ, López MJ, Vassena R, Coll O, Vernaeve V.
J Ultrasound Med. 2014 Apr;33(4):649-55. doi: 10.7863/ultra.33.4.649.

Individualized embryo transfer training: timing and performance
López MJ, García D, Rodríguez A, Colodrón M, Vassena R, Vernaeve V.
Hum Reprod. 2014 Apr 29

Training in empathic skills improves the patient physician relationship during the first consultation in a fertility clinic
García D, Bautista O, Venereo L, Coll O, Vassena R, Vernaeve V.
Fertil Steril. 2013 Apr;99(5):1413-1418.e1. Epub 2013 Jan 5

Transvaginal versus transabdominal ultrasound guidance for embryo transfer in donor oocyte recipients: a randomized clinical trial
Bodri D, Colodrón M, García D, Obradors A, Vernaeve V, Coll O.
Fertil Steril. 2011 Jun;95(7):2263-2268.e1. Epub 2011 Apr

Blastocyst culture is associated with an elevated incidence of monozygotic twinning after single embryo transfer
Kawachiya S, Bodri D, Shimada N, Kato K, Takehara Y, Kato O.
Fertil Steril. 2011 May;95(6):2140-2. Epub 2011 Jan 7

Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations
López M, Coll O.
Fetal Diagn Ther. 2010 Jul;28(1):1-8. Epub 2010 Jun 19

Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis
Bodri D, Sunkara SK, Coomarasamy A.
Fertil Steril. 2011 Jan;95(1):164-9. Epub 2010 Aug 4

Racial disparity in oocyte donation outcome: a multiethnic, matched cohort study.
Bodri D, Guillén JJ, López M, Vernaeve V, Coll O.
Hum Reprod. 2010 Feb;25(2):436-42. Epub 2009 Nov 24

Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study
Bodri D, Guillén JJ, Trullenque M, Schwenn K, Esteve C, Coll O.
Fertil Steril. 2010 May 1;93(7):2418-20. Epub 2009 Oct 2

Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial
Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O.
Gynecol Endocrinol. 2009 Jan;25(1):60-6.

Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients
Bodri D, Guillén JJ, Schwenn K, Casadesus S, Vidal R, Coll O.
Fertil Steril. 2009 Apr;91(4 Suppl):1489-92.

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study
Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
Fertil Steril. 2009 Feb;91(2):365-71.

Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.
López S, Coll O, Durban M, Hernàndez S, Vidal R, Suy A, Morén C, Casademont J, Cardellach F, Mataró D, Miró O, Garrabou G.
Antivir Ther. 2008;13(6):833-8.

Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles
Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O.
Reprod Biomed Online. 2008 Aug;17(2):237-43.

Fertility choices and management for HIV-positive women
Coll O, Lopez M, Hernandez S.
Curr Opin HIV AIDS. 2008 Mar;3(2):186-92.

Le diagostic préimplantatoire (DPI) actuellement en Espagne
Polo A, Vidal R, Bodri D, Coll O.
La lettre du Gynécologue 2008; 335:25-27

Prognostic factors in oocyte donation: an analysis through egg-sharing recipient pairs showing a discordant outcome
Bodri D, Colodron M, Vidal R, Galindo A, Durban M, Coll O.
Fertil Steril. 2007 Dec;88(6):1548-53.

Endometrial receptivity after oocyte donation in recipients with a history of chemotherapy and/or radiotherapy
Vernaeve V, Bodri D, Colodrón M, Vidal R, Durbán M, Coll O.
Hum Reprod. 2007 Nov;22(11):2863-7.

Fertility assessment in non-infertile HIV-infected women and their partners
Coll O, López M, Vidal R, Figueras F, Suy A, Hernández S, Loncà M, Palacio M, Martínez E, Vernaeve V.
Reprod Biomed Online. 2007 Apr;14(4):488-94.

Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial
Bodri D, Vernaeve V, Guillén JJ, Vidal R, Figueras F, Coll O.
Hum Reprod. 2006 Sep;21(9):2246-51.

How successful is repeat testicular sperm extraction in patients with azoospermia?
Vernaeve V, Verheyen G, Goossens A, Van Steirteghem A, Devroey P, Tournaye H.
Hum Reprod. 2006 Jun;21(6):1551-4.

Oocyte donation in patients with Turner’s syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy
Bodri D, Vernaeve V, Figueras F, Vidal R, Guillén JJ, Coll O.
Hum Reprod. 2006 Mar;21(3):829-32.

Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART
Coll O, Suy A, Figueras F, Vernaeve V, Martínez E, Mataró D, Durban M, Lonca M, Vidal R, Gatell JM.
AIDS. 2006 Jan 2;20(1):121-3.

Última actualización: Febrero, 2017
Descubre ahora cómo podemos ayudarte